Financhill
Back

SpringWorks Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
55

SWTX
SpringWorks Therapeutics

Last Price:
38.69
Seasonality Move:
7.72%
Sell
41

ALNY
Alnylam Pharmaceuticals

Last Price:
161.63
Seasonality Move:
19.62%
Buy
55
SpringWorks Therapeutics (SWTX) is a Buy

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $39.07. The Score for SWTX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $160.00. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $39.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $160.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.3 Sell
Relative Strength Index (14 RSI): 40.32 Sell
Chaikin Money Flow: 72082 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.69 - 43.57) Sell
Bollinger Bands (100): (41.83 - 49.09) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.99 Buy
Relative Strength Index (14 RSI): 66.19 Buy
Chaikin Money Flow: 91249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (147.76 - 154.18) Buy
Bollinger Bands (100): (144.34 - 164.7) Buy

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.54 Sell
20-day SMA: 41.37 Sell
50-day SMA: 42.88 Sell
200-day SMA: 36.75 Buy
8-day EMA: 39.66 Sell
20-day EMA: 40.93 Sell
50-day EMA: 42.67 Sell
200-day EMA: 39.04 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 154.11 Buy
20-day SMA: 151.37 Buy
50-day SMA: 149.96 Buy
200-day SMA: 166.05 Sell
8-day EMA: 155.2 Buy
20-day EMA: 152.43 Buy
50-day EMA: 151.83 Buy
200-day EMA: 164.7 Sell

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $1.45 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.49 per share, and an increase next year of $1.76 per share.

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):